Cunningham Ann Michelle 4
4 · VistaGen Therapeutics, Inc. · Filed May 4, 2021
Insider Transaction Report
Form 4
Cunningham Ann Michelle
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-05-01+300,000→ 300,000 totalExercise: $2.53Exp: 2031-05-01→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]25% of the stock options vest on the one-year anniversary of the grant date, with the remaining 75% vesting ratably on a monthly basis over the 36 months thereafter. Stock options were granted in connection with the Reporting Person's appointment to the Issuer's Board of Directors and pursuant to the Issuer's 2019 Omnibus Equity Incentive Plan.